Analysis of human neurological disorders using mutagenesis in the mouse

Clinical Science

Volumn 108, Issue 5, 2005, Pages 385-397

  Oliver, Peter L ^a   Davies, Kay E ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Ataxia; Cerebellum; Mutagenesis; Neurological disorder; Peripheral neuropathy

Indexed keywords

PROTEIN ALF; PROTEIN DERIVATIVE; PROTEIN PMP22; PROTEIN SIAH; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; CELL LOSS; CELL MUTANT; CEREBELLAR ATAXIA; GENE TARGETING; MOUSE; MOUSE MUTANT; MUTAGENESIS; MYELINATION; NEUROLOGIC DISEASE; NONHUMAN; PERIPHERAL NERVE; PERIPHERAL NEUROPATHY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN FAMILY; PROTEIN FUNCTION; PURKINJE CELL; REVIEW;

ANIMALS; CEREBELLAR ATAXIA; DISEASE MODELS, ANIMAL; HUMANS; MICE; MICE, MUTANT STRAINS; MUTAGENESIS; MYELIN PROTEINS; NERVOUS SYSTEM DISEASES; NUCLEAR PROTEINS; PERIPHERAL NERVOUS SYSTEM DISEASES; TRANSCRIPTION FACTORS; UBIQUITIN-PROTEIN LIGASES;

EID: 18844451196     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20050041     Document Type: Review

References (112)

1. Benzer, S. (1971) From the gene to behavior. JAMA, J. Am. Med. Assoc. 218, 1015-1022
2. Nusslein-Volhard, C. and Wieschaus, E. (1980) Mutations affecting segment number and polarity in Drosophila. Nature (London) 287, 795-801
3. Hirsh, D. and Vanderslice, R. (1976) Temperature-sensitive developmental mutants of Caenorhabditis elegans. Dev. Biol. 49, 220-235
4. Haffter, P., Granato, M., Brand, M. et al. (1996) The identification of genes with unique and essential functions in the development of the zebrafish, Danio rerio. Development 123, 1-36
5. Driscoll, M. and Gerstbrein, B. (2003) Dying for a cause: invertebrate genetics takes on human neurodegeneration. Nat. Rev. Genet. 4, 181-194
6. Bonini, N. M. and Fortini, M. E. (2003) Human neurodegenerative disease modeling using Drosophila. Annu. Rev. Neurosci. 26, 627-656
7. Denny, P. and Justice, M. J. (2000) Mouse as the measure of man? Trends Genet. 16, 283-287
8. Brown, S. D. and Nolan, P. M. (1998) Mouse mutagenesis-systematic studies of mammalian gene function. Hum. Mol. Genet. 7, 1627-1633
9. Brown, S. D. and Balling, R. (2001) Systematic approaches to mouse mutagenesis. Curr. Opin. Genet. Dev. 11, 268-273
10. Beckers, J. and Hrabe de Angelis, M. (2002) Large-scale mutational analysis for the annotation of the mouse genome. Curr. Opin. Chem. Biol. 6, 17-23
11. Justice, M. J. (2000) Capitalizing on large-scale mouse mutagenesis screens. Nat. Rev. Genet. 1, 109-115
12. Hitotsumachi, S., Carpenter, D. A. and Russell, W. L. (1985) Dose-repetition increases the mutagenic effectiveness of N-ethyl-N-nitrosourea in mouse spermatogonia. Proc. Natl. Acad. Sci. U.S.A. 82, 6619-6621
13. Nolan, P. M., Peters, J., Strivens, M. et al. (2000) A systematic, genome-wide, phenotype-driven mutagenesis programme for gene function studies in the mouse. Nat. Genet. 25, 440-443
14. Hrabe de Angelis, M. H., Flaswinkel, H., Fuchs, H. et al. (2000) Genome-wide, large-scale production of mutant mice by ENU mutagenesis. Nat. Genet. 25, 444-447
15. Goldowitz, D., Frankel, W. N., Takahashi, J. S. et al. (2004) Large-scale mutagenesis of the mouse to understand the genetic bases of nervous system structure and function. Brain Res. Mol. Brain Res. 132, 105-115
16. Thaung, C., West, K., Clark, B. J. et al. (2002) Novel ENU-induced eye mutations in the mouse: models for human eye disease. Hum. Mol. Genet. 11, 755-767
17. Rogers, D. C., Fisher, E. M., Brown, S. D., Peters, J., Hunter, A. J. and Martin, J. E. (1997) Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment. Mamm. Genome 8, 711-713
18. Glenister, P. H. and Thornton, C. E. (2000) Cryoconservation-archiving for the future. Mamm. Genome 11, 565-571
19. Kile, B. T., Hentges, K. E., Clark, A. T. et al. (2003) Functional genetic analysis of mouse chromosome 11. Nature (London) 425, 81-86
20. McKusick, V. A. (1998) Mendelian Inheritance in Man, Johns Hopkins University Press, Baltimore
21. Li, Q., Liu, Z., Monroe, H. and Culiat, C. T. (2002) Integrated platform for detection of DNA sequence variants using capillary array electrophoresis. Electrophoresis 23, 1499-1511
22. Munroe, R. J., Ackerman, S. L. and Schimenti, J. C. (2004) Genomewide two-generation screens for recessive mutations by ES cell mutagenesis. Mamm. Genome 15, 960-965
23. Quwailid, M. M., Hugill, A., Dear, N. et al. (2004) A gene-driven ENU-based approach to generating an allelic series in any gene. Mamm. Genome 15, 585-591
24. Coghill, E. L., Hugill, A., Parkinson, N. et al. (2002) A gene-driven approach to the identification of ENU mutants in the mouse. Nat. Genet. 30, 255-256
25. Nadeau, J. H. (2000) Muta-genetics or muta-genomics: the feasibility of large-scale mutagenesis and phenotyping programs. Mamm. Genome 11, 603-607
26. Williams, R. W., Flaherty, L. and Threadgill, D. W. (2003) The math of making mutant mice. Genes Brain Behav. 2, 191-200
27. Bucan, M. and Abel, T. (2002) The mouse: genetics meets behaviour. Nat. Rev. Genet. 3, 114-123
28. Tarantino, L. M. and Bucan, M. (2000) Dissection of behavior and psychiatric disorders using the mouse as a model. Hum. Mol. Genet. 9, 953-965
29. Ohl, F. and Keck, M. E. (2003) Behavioural screening in mutagenised mice: in search for novel animal models of psychiatric disorders. Eur. J. Pharmacol. 480, 219-228
30. Rogers, D. C., Peters, J., Martin, J. E. et al. (2001) SHIRPA, a protocol for behavioral assessment: validation for longitudinal study of neurological dysfunction in mice. Neurosci. Lett. 306, 89-92
31. Bacon, Y., Ooi, A., Kerr, S. et al. (2004) Screening for novel ENU-induced rhythm, entrainment and activity mutants. Genes Brain Behav. 3, 196-205
32. Keays, D. A. and Nolan, P. M. (2003) N-ethyl-N-nitrosourea mouse mutants in the dissection of behavioural and psychiatric disorders. Eur. J. Pharmacol. 480, 205-217
33. Rastan, S., Hough, T., Kierman, A. et al. (2004) Towards a mutant map of the mouse: new models of neurological, behavioural, deafness, bone, renal and blood disorders. Genetica 122, 47-49
34. Davis, A. P. and Justice, M. J. (1998) Mouse alleles: if you've seen one, you haven't seen them all. Trends Genet. 14, 438-441
35. v1.6) and a genetically linked retinal mutation, rd13. Mamm. Genome 15, 344-351
36. Russell, W. L., Kelly, E. M., Hunsicker, P. R., Bangham, J. W., Maddux, S. C. and Phipps, E. L. (1979) Specific-locus test shows ethylnitrosourea to be the most potent mutagen in the mouse. Proc. Natl. Acad. Sci. U.S.A. 76, 5818-5819
37. Hafezparast, M., Klocke, R., Ruhrberg, C. et al. (2003) Mutations in dynein link motor neuron degeneration to defects in retrograde transport. Science 300, 808-812
38. Karhunen, P. J., Erkinjuntti, T. and Laippala, P. (1994) Moderate alcohol consumption and loss of cerebellar Purkinje cells. Br. Med. J. 308, 1663-1667
39. Campuzano, V., Montermini, L., Molto, M. D. et al. (1996) Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 271, 1423-1427
40. Schols, L., Bauer, P., Schmidt, T., Schulte, T. and Riess, O. (2004) Autosomal dominant cerebellar ataxias: clinical features, genetics and pathogenesis. Lancet Neurol. 3, 291-304
41. Pentchev, P. G., Vanier, M. T., Suzuki, K. and Patterson, M. C. (1995) Niemann-Pick disease types C: a cellular cholesterol lipidosis. In The Metabolic and Molecular Bases of Inherited Disease (Scriver, C. R., Beaudet, A. L., Sly, W. S. and Valle, D., eds.), pp. 2625-2640, McGraw-Hill, New York
42. Schuchman, E. H. and Desnick, R. J. (1995) Niemann-Pick Disease types A and B: acid sphingomyelinase deficiencies. In The Metabolic and Molecular Bases of Inherited Disease (Scriver, C. R., Beaudet, A. L., Sly, W. S. and Valle, D., eds.), pp. 2601-2624, McGraw-Hill, New York
43. Manto, M.-U. and Pandolfo, M. (2001) The Cerebellum and its Disorders, Cambridge University Press, Cambridge
44. Orr, H. T. and Zoghbi, H. Y. (2001) SCA1 molecular genetics: a history of a 13 year collaboration against glutamines. Hum. Mol. Genet. 10, 2307-2311
45. Heintz, N. and Zoghbi, H. Y. (2000) Insights from mouse models into the molecular basis of neurodegeneration. Annu. Rev. Physiol. 62, 779-802
46. Isaacs, A. M., Oliver, P. L., Jones, E. L. et al. (2003) A mutation in Af4 is predicted to cause cerebellar ataxia and cataracts in the robotic mouse. J. Neurosci. 23, 1631-1637
47. Higashi, Y., Murayama, S., Pentchev, P. G. and Suzuki, K. (1993) Cerebellar degeneration in the Niemann-Pick type C mouse. Acta Neuropathol. (Berl) 85, 175-184
48. Sarna, J., Miranda, S. R., Schuchman, E. H. and Hawkes, R. (2001) Patterned cerebellar Purkinje cell death in a transgenic mouse model of Niemann Pick type A/B disease. Eur. J. Neurosci. 13, 1873-1880
49. Domer, P. H., Fakharzadeh, S. S., Chen, C. S. et al. (1993) Acute mixed-lineage leukemia t(4;11)(q21;q23) generates an MLL-AF4 fusion product. Proc. Natl. Acad. Sci. U.S.A. 90, 7884-7888
50. Isnard, P., Depetris, D., Mattei, M. G., Ferrier, P. and Djabali, M. (1998) cDNA cloning, expression and chromosomal localization of the murine AF-4 gene involved in human leukemia. Mamm. Genome 9, 1065-1068
51. Isnard, P., Core, N., Naquet, P. and Djabali, M. (2000) Altered lymphoid development in mice deficient for the mAF4 proto-oncogene. Blood 96, 705-710
52. Gu, Y., Shen, Y., Gibbs, R. A. and Nelson, D. L. (1996) Identification of FMR2, a novel gene associated with the FRAXE CCG repeat and CpG island. Nat. Genet. 13, 109-113
53. Ma, C. and Staudt, L. M. (1996) LAF-4 encodes a lymphoid nuclear protein with transactivation potential that is homologous to AF-4, the gene fused to MLL in t(4;11) leukemias. Blood 87, 734-745
54. Gecz, J., Gedeon, A. K., Sutherland, G. R. and Mulley, J. C. (1996) Identification of the gene FMR2, associated with FRAXE mental retardation. Nat. Genet. 13, 105-108
55. Nilson, I., Reichel, M., Ennas, M. G. et al. (1997) Exon/intron structure of the human AF-4 gene, a member of the AF-4/LAF-4/FMR-2 gene family coding for a nuclear protein with structural alterations in acute leukaemia. Br. J. Haematol. 98, 157-169
56. Taki, T., Kano, H., Taniwaki, M., Sako, M., Yanagisawa, M. and Hayashi, Y. (1999) AF5q31, a newly identified AF4-related gene, is fused to MLL in infant acute lymphoblastic leukemia with ins(5;11)(q31;q13q23). Proc. Natl. Acad. Sci. U.S.A. 96, 14535-14540
57. Prasad, R., Yano, T., Sorio, C. et al. (1995) Domains with transcriptional regulatory activity within the ALL1 and AF4 proteins involved in acute leukemia. Proc. Natl. Acad. Sci. U.S.A. 92, 12160-12164
58. Hillman, M. A. and Gecz, J. (2001) Fragile XE-associated familial mental retardation protein 2 (FMR2) acts as a potent transcription activator. J. Hum. Genet. 46, 251-259
59. Oliver, P. L., Bitoun, E., Clark, J., Jones, E. L. and Davies, K. E. (2004) Mediation of Af4 protein function in the cerebellum by Siah proteins. Proc. Natl. Acad. Sci. U.S.A. 101, 14901-14906
60. von Bergh, A. R., Beverloo, H. B., Rombout, P. et al. (2002) LAF4, an AF4-related gene, is, fused to MLL in infant acute lymphoblastic leukemia. Genes Chromosomes Cancer 35, 92-96
61. Rowley, J. D. (1998) The critical role of chromosome translocations in human leukemias. Annu. Rev. Genet. 32, 495-519
62. Bursen, A., Moritz, S., Gaussmann, A., Dingermann, T. and Marschalek, R. (2004) Interaction of AF4 wild-type and AF4.MLL fusion protein with SIAH proteins: indication for t(4;11) pathobiology? Oncogene 23, 6237-6249
63. Dobson, C. L., Warren, A. J., Pannell, R., Forster, A. and Rabbins, T. H. (2000) Tumorigenesis in mice with a fusion of the leukaemia oncogene MH and the bacterial lacZ gene. EMBO J. 19, 843-851
64. Gecz, J. (2000) The FMR2 gene, FRAXE and non-specific X-linked mental retardation: clinical and molecular aspects. Ann. Hum. Genet. 64, 95-106
65. Gu, Y., McIlwain, K. L., Weeber, E. J. et al. (2002) Impaired conditioned fear and enhanced long-term potentiation in Fmr2 knock-out mice. J. Neurosci. 22, 2753-2763
66. Tang, A. H., Neufeld, T. P., Rubin, G. M. and Muller, H. A. (2001) Transcriptional regulation of cytoskeletal functions and segmentation by a novel maternal pair-rule gene, lilliputian. Development 128, 801-813
67. Wittwer, F., van der Straten, A., Keleman, K., Dickson, B. J. and Hafen, E. (2001) Lilliputian: an AF4/FMR2-related protein that controls cell identity and cell growth. Development 128, 791-800
68. Gu, Y. and Nelson, D. L. (2003) FMR2 function: insight from a mouse knockout model. Cytogenet Genome Res. 100, 129-139
69. Chakrabarti, L., Bristulf, J., Foss, G. S. and Davies, K. E. (1998) Expression of the murine homologue of FMR2 in mouse brain and during development. Hum. Mol. Genet. 7, 441-448
70. Weissman, A. M. (2001) Themes and variations on ubiquitylation. Nat. Rev. Mol. Cell. Biol. 2, 169-178
71. Venables, J. P., Dalgliesh, C., Paronetto, M. P. et al. (2004) SIAH1 targets the alternative splicing factor T-STAR for degradation by the proteasome. Hum. Mol. Genet. 13, 1525-1534
72. House, C. M., Frew, I. J., Huang, H. L. et al. (2003) A binding motif for Siah ubiquitin ligase. Proc. Natl. Acad. Sci. U.S.A. 100, 3101-3106
73. Dobson, C. L., Warren, A. J., Pannell, R. et al. (1999) The mll-AF9 gene fusion in mice controls myeloproliferation and specifies acute myeloid leukaemogenesis. EMBO J. 18, 3564-3574
74. Erfurth, F., Hemenway, C. S., de Erkenez, A. C. and Domer, P. H. (2004) MLL fusion partners AF4 and AF9 interact at subnuclear foci. Leukemia 18, 92-102
75. Raine, C. (1984) Morphology of myelin and myelination. In Myelin (Morrell, P., ed.), pp. 259-310, Plenum Press, New York
76. Snell, R. S. (1987) Nerve fibres and peripheral nerves. In Clinical Neuroanatomy for Medical Students, pp. 91-122, Little, Brown and Company, Boston
77. Vedeler, C. A. (2000) Inflammatory neuropathies: update. Curr. Opin. Neurol. 13, 305-309
78. Suter, U. and Scherer, S. S. (2003) Disease mechanisms in inherited neuropathies. Nat. Rev. Neurosci. 4, 714-726
79. Boerkoel, C. F., Takashima, H., Garcia, C. A. et al. (2002) Charcot-Marie-Tooth disease and related neuropathies: mutation distribution and genotype-phenotype correlation. Ann. Neurol. 51, 190-201
80. Nelis, E., Haites, N. and Van Broeckhoven, C. (1999) Mutations in the peripheral myelin genes and associated genes in inherited peripheral neuropathies. Hum. Mutat. 13, 11-28
81. Chance, P. F., Alderson, M. K., Leppig, K. A. et al. (1993) DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell 72, 143-151
82. Vallat, J. M., Sindou, P., Preux, P. M. et al. (1996) Ultrastructural PMP22 expression in inherited demyelinating neuropathies. Ann. Neurol. 39, 813-817
83. Adlkofer, K., Martini, R., Aguzzi, A., Zielasek, J., Toyka, K. V. and Suter, U. (1995) Hypermyelination and demyelinating peripheral neuropathy in Pmp22-deficient mice. Nat. Genet. 11, 274-280
84. Zoidl, G., Blass-Kampmann, S., D'Urso, D., Schmalenbach, C. and Muller, H. W. (1995) Retroviral-mediated gene transfer of the peripheral myelin protein PMP22 in Schwann cells: modulation of cell growth. EMBO J. 14, 1122-1128
85. Brancolini, C., Marzinotto, S., Edomi, P., Agostoni, E., Fiorentini, C., Muller, H. W. and Schneider, C. (1999) Rho-dependent regulation of cell spreading by the tetraspan membrane protein Gas3/PMP22. Mol. Biol. Cell 10, 2441-2459
86. Erne, B., Sansano, S., Frank, M. and Schaeren-Wiemers, N. (2002) Rafts in adult peripheral nerve myelin contain major structural myelin proteins and myelin and lymphocyte protein (MAL) and CD59 as specific markers. J. Neurochem. 82, 550-562
87. Naef, R. and Suter, U. (1999) Impaired intracellular trafficking is a common disease mechanism of PMP22 point mutations in peripheral neuropathies. Neurobiol. Dis. 6, 1-14
88. Naef, R., Adlkofer, K., Lescher, B. and Suter, U. (1997) Aberrant protein trafficking in Trembler suggests a disease mechanism for hereditary human peripheral neuropathies. Mol. Cell. Neurosci. 9, 13-25
89. Notterpek, L., Ryan, M. C., Tobler, A. R. and Shooter, E. M. (1999) PMP22 accumulation in aggresomes: implications for CMT1A pathology. Neurobiol. Dis. 6, 450-460
90. D'Urso, D., Prior, R., Greiner-Petter, R., Gabreels-Festen, A. A. and Muller, H. W. (1998) Overloaded endoplasmic reticulum-Golgi compartments, a possible pathomechanism of peripheral neuropathies caused by mutations of the peripheral myelin protein PMP22. J. Neurosci. 18, 731-740
91. Tobler, A. R., Notterpek, E., Naef, R., Taylor, V., Suter, U. and Shooter, E. M. (1999) Transport of Trembler-J mutant peripheral myelin protein 22 is blocked in the intermediate compartment and affects the transport of the wild-type protein by direct interaction. J. Neurosci. 19, 2027-2036
92. Colby, J., Nicholson, R., Dickson, K. M., Orfali, W., Naef, R., Suter, U. and Snipes, G. J. (2000) PMP22 carrying the trembler or trembler-J mutation is intracellularly retained in myelinating Schwann cells. Neurobiol. Dis. 7, 561-573
93. Ryan, M. C., Shooter, E. M. and Notterpek, E. (2002) Aggresome formation in neuropathy models based on peripheral myelin protein 22 mutations. Neurobiol. Dis. 10, 109-118
94. Isaacs, A. M., Davies, K. E., Hunter, A. J. et al. (2000) Identification of two new Pmp22 mouse mutants using large-scale mutagenesis and a novel rapid mapping strategy. Hum. Mol. Genet. 9, 1865-1871
95. Isaacs, A. M., Jeans, A., Oliver, P. E., Vizor, E., Brown, S. D., Hunter, A. J. and Davies, K. E. (2002) Identification of a new Pmp22 mouse mutant and trafficking analysis of a Pmp22 allelic series suggesting that protein aggregates may be protective in Pmp22-associated peripheral neuropathy. Mol. Cell. Neurosci. 21, 114-125
96. Valentijn, L. J., Ouvrier, R. A., van den Bosch, N. H., Bolhuis, P. A., Baas, F. and Nicholson, G. A. (1995) Dejerme-Sottas neuropathy is associated with a de novo PMP22 mutation. Hum. Mutat. 5, 76-80
97. Marques, Jr, W., Thomas, P. K., Sweeney, M. G., Carr, E. and Wood, N. W. (1998) Dejerine-Sottas neuropathy and PMP22 point mutations: a new base pair substitution and a possible 'hot spot' on Ser72. Ann. Neurol. 43, 680-683
98. Marques, Jr, W., Neto, J. M. and Barreira, A. A. (2004) Dejerine-Sottas' neuropathy caused by the missense mutation PMP22 Ser72Leu. Acta Neurol. Scand. 110, 196-199
99. Ekici, A. B., Park, O., Korinthenberg, R., Grehl, H. and Rautenstrauss, B. (2001) T → C transition in codon 72 (TCG → CCG), S72P, a putative hotspot in PMP22. Hum. Mutat. 17, 81
100. Suter, U., Moskow, J. J., Welcher, A. A. et al. (1992) A leucine-to-proline mutation in the putative first transmembrane domain of the 22-kDa peripheral myelin protein in the trembler-J mouse. Proc. Natl. Acad. Sci. U.S.A. 89, 4382-4386
101. Ionasescu, V. V., Searby, C. C., Ionasescu, R., Chatkupt, S., Patel, N. and Koenigsberger, R. (1997) Dejerine-Sottas neuropathy in mother and son with same point mutation of PMP22 gene. Muscle Nerve 20, 97-99
102. Valentijn, L. J., Baas, F., Wolterman, R. A. et al. (1992) Identical point mutations of PMP-22 in Trembler-J mouse and Charcot-Marie-Tooth disease type 1A. Nat. Genet. 2, 288-291
103. Pareek, S., Notterpek, L., Snipes, G. J. et al. (1997) Neurons promote the translocation of peripheral myelin protein 22 into myelin. J. Neurosci. 17, 7754-7762
104. Johnston, J. A., Ward, C. L. and Kopito, R. R. (1998) Aggresomes: a cellular response to misfolded proteins. J. Cell Biol. 143, 1883-1898
105. Notterpek, L., Shooter, E. M. and Snipes, G. J. (1997) Upregulation of the endosomal-lysosomal pathway in the trembler-J neuropathy. J. Neurosci. 17, 4190-4200
106. Fortun, J., Dunn, Jr, W. A., Joy, S., Li, J. and Notterpek, L. (2003) Emerging role for autophagy in the removal of aggresomes in Schwann cells. J. Neurosci. 23, 10672-10680
107. Taylor, J. P., Tanaka, F., Robitschek, J., Sandoval, C. M., Taye, A., Markovic-Plese, S. and Fischbeck, K. H. (2003) Aggresomes protect cells by enhancing the degradation of toxic polyglutamine-containing protein. Hum. Mol. Genet. 12, 749-757
108. Tanaka, M., Kim, Y. M., Lee, G., Junn, E., Iwatsubo, T. and Mouradian, M. M. (2004) Aggresomes formed by α-synuclein and synphilin-1 are cytoprotective. J. Biol. Chem. 279, 4625-4631
109. Elsea, S. H. and Lucas, R. E. (2002) The mousetrap: what we can learn when the mouse model does not mimic the human disease. Ilar J. 43, 66-79
110. Watase, K. and Zoghbi, H. Y. (2003) Modelling brain diseases in mice: the challenges of design and analysis. Nat. Rev. Genet. 4, 296-307
111. Sango, K., Yamanaka, S., Hoffmann, A. et al. (1995) Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism. Nat. Genet. 11, 170-176
112. Phaneuf, D., Wakamatsu, N., Huang, J. Q. et al. (1996) Dramatically different phenotypes in mouse models of human Tay-Sachs and Sandhoff diseases. Hum. Mol. Genet. 5, 1-14